Logo image of CREX

CREATIVE REALITIES INC (CREX) Stock Fundamental Analysis

USA - NASDAQ:CREX - US22530J3095 - Common Stock

2.31 USD
-0.16 (-6.48%)
Last: 9/25/2025, 8:00:00 PM
Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to CREX. CREX was compared to 100 industry peers in the Media industry. CREX may be in some trouble as it scores bad on both profitability and health. CREX has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

In the past year CREX was profitable.
In the past year CREX has reported a negative cash flow from operations.
In multiple years CREX reported negative net income over the last 5 years.
In multiple years CREX reported negative operating cash flow during the last 5 years.
CREX Yearly Net Income VS EBIT VS OCF VS FCFCREX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M -10M -15M

1.2 Ratios

CREX's Return On Assets of -0.05% is in line compared to the rest of the industry. CREX outperforms 56.00% of its industry peers.
Looking at the Return On Equity, with a value of -0.10%, CREX is in line with its industry, outperforming 58.00% of the companies in the same industry.
Looking at the Return On Invested Capital, with a value of 0.43%, CREX is in line with its industry, outperforming 41.00% of the companies in the same industry.
Industry RankSector Rank
ROA -0.05%
ROE -0.1%
ROIC 0.43%
ROA(3y)-2.23%
ROA(5y)-17.47%
ROE(3y)-5.54%
ROE(5y)-80.4%
ROIC(3y)N/A
ROIC(5y)N/A
CREX Yearly ROA, ROE, ROICCREX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100 -200 -300

1.3 Margins

CREX's Operating Margin of 0.60% is on the low side compared to the rest of the industry. CREX is outperformed by 61.00% of its industry peers.
CREX has a Gross Margin (46.99%) which is in line with its industry peers.
CREX's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 0.6%
PM (TTM) N/A
GM 47%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.36%
GM growth 5Y1.66%
CREX Yearly Profit, Operating, Gross MarginsCREX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50

2

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), CREX is destroying value.
The number of shares outstanding for CREX has been increased compared to 1 year ago.
Compared to 5 years ago, CREX has more shares outstanding
Compared to 1 year ago, CREX has a worse debt to assets ratio.
CREX Yearly Shares OutstandingCREX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
CREX Yearly Total Debt VS Total AssetsCREX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

2.2 Solvency

CREX has an Altman-Z score of 0.07. This is a bad value and indicates that CREX is not financially healthy and even has some risk of bankruptcy.
CREX's Altman-Z score of 0.07 is on the low side compared to the rest of the industry. CREX is outperformed by 70.00% of its industry peers.
CREX has a Debt/Equity ratio of 0.78. This is a neutral value indicating CREX is somewhat dependend on debt financing.
With a Debt to Equity ratio value of 0.78, CREX perfoms like the industry average, outperforming 53.00% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.78
Debt/FCF N/A
Altman-Z 0.07
ROIC/WACC0.06
WACC6.99%
CREX Yearly LT Debt VS Equity VS FCFCREX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M

2.3 Liquidity

A Current Ratio of 1.23 indicates that CREX should not have too much problems paying its short term obligations.
CREX has a Current ratio (1.23) which is in line with its industry peers.
A Quick Ratio of 1.10 indicates that CREX should not have too much problems paying its short term obligations.
With a Quick ratio value of 1.10, CREX perfoms like the industry average, outperforming 44.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.23
Quick Ratio 1.1
CREX Yearly Current Assets VS Current LiabilitesCREX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M

6

3. Growth

3.1 Past

CREX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 488.89%, which is quite impressive.
CREX shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 12.59%.
Measured over the past years, CREX shows a quite strong growth in Revenue. The Revenue has been growing by 9.98% on average per year.
EPS 1Y (TTM)488.89%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-183.33%
Revenue 1Y (TTM)12.59%
Revenue growth 3Y40.23%
Revenue growth 5Y9.98%
Sales Q2Q%-0.65%

3.2 Future

The Earnings Per Share is expected to grow by 53.47% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 11.12% on average over the next years. This is quite good.
EPS Next Y144.82%
EPS Next 2Y53.47%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year4.11%
Revenue Next 2Y11.12%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
CREX Yearly Revenue VS EstimatesCREX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 20M 40M 60M 80M 100M
CREX Yearly EPS VS EstimatesCREX Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 -1 -2 -3

5

4. Valuation

4.1 Price/Earnings Ratio

CREX is valuated cheaply with a Price/Earnings ratio of 6.60.
90.00% of the companies in the same industry are more expensive than CREX, based on the Price/Earnings ratio.
Compared to an average S&P500 Price/Earnings ratio of 27.06, CREX is valued rather cheaply.
Based on the Price/Forward Earnings ratio of 19.69, the valuation of CREX can be described as rather expensive.
The rest of the industry has a similar Price/Forward Earnings ratio as CREX.
CREX's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 22.64.
Industry RankSector Rank
PE 6.6
Fwd PE 19.69
CREX Price Earnings VS Forward Price EarningsCREX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CREX is valued a bit cheaper than 63.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 9.75
CREX Per share dataCREX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4

4.3 Compensation for Growth

CREX's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
CREX's earnings are expected to grow with 53.47% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.05
PEG (5Y)N/A
EPS Next 2Y53.47%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

CREX does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

CREATIVE REALITIES INC

NASDAQ:CREX (9/25/2025, 8:00:00 PM)

2.31

-0.16 (-6.48%)

Chartmill FA Rating
GICS IndustryGroupMedia & Entertainment
GICS IndustryMedia
Earnings (Last)08-13 2025-08-13/bmo
Earnings (Next)11-11 2025-11-11/bmo
Inst Owners15.67%
Inst Owner Change24.5%
Ins Owners17.62%
Ins Owner Change25.71%
Market Cap24.30M
Analysts84
Price Target6.76 (192.64%)
Short Float %1.5%
Short Ratio1.76
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)230.68%
Min EPS beat(2)-140.1%
Max EPS beat(2)601.45%
EPS beat(4)3
Avg EPS beat(4)160.43%
Min EPS beat(4)-140.1%
Max EPS beat(4)601.45%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-3.64%
Min Revenue beat(2)-11.52%
Max Revenue beat(2)4.23%
Revenue beat(4)3
Avg Revenue beat(4)-0.84%
Min Revenue beat(4)-11.52%
Max Revenue beat(4)4.23%
Revenue beat(8)3
Avg Revenue beat(8)-4.2%
Revenue beat(12)3
Avg Revenue beat(12)-4.26%
Revenue beat(16)3
Avg Revenue beat(16)-3.68%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)13.04%
EPS NY rev (1m)0%
EPS NY rev (3m)166.67%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)-0.13%
Revenue NY rev (3m)-4.74%
Valuation
Industry RankSector Rank
PE 6.6
Fwd PE 19.69
P/S 0.5
P/FCF N/A
P/OCF N/A
P/B 0.81
P/tB N/A
EV/EBITDA 9.75
EPS(TTM)0.35
EY15.15%
EPS(NY)0.12
Fwd EY5.08%
FCF(TTM)-0.34
FCFYN/A
OCF(TTM)-0.1
OCFYN/A
SpS4.59
BVpS2.84
TBVpS-1.8
PEG (NY)0.05
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.05%
ROE -0.1%
ROCE 0.55%
ROIC 0.43%
ROICexc 0.44%
ROICexgc 6.2%
OM 0.6%
PM (TTM) N/A
GM 47%
FCFM N/A
ROA(3y)-2.23%
ROA(5y)-17.47%
ROE(3y)-5.54%
ROE(5y)-80.4%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.36%
GM growth 5Y1.66%
F-Score3
Asset Turnover0.72
Health
Industry RankSector Rank
Debt/Equity 0.78
Debt/FCF N/A
Debt/EBITDA 4.93
Cap/Depr 58.56%
Cap/Sales 5.37%
Interest Coverage 0.26
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.23
Quick Ratio 1.1
Altman-Z 0.07
F-Score3
WACC6.99%
ROIC/WACC0.06
Cap/Depr(3y)115.1%
Cap/Depr(5y)95.1%
Cap/Sales(3y)8.11%
Cap/Sales(5y)6.88%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)488.89%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-183.33%
EPS Next Y144.82%
EPS Next 2Y53.47%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)12.59%
Revenue growth 3Y40.23%
Revenue growth 5Y9.98%
Sales Q2Q%-0.65%
Revenue Next Year4.11%
Revenue Next 2Y11.12%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-78.53%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year709.43%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-40%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-151.33%
OCF growth 3Y93.04%
OCF growth 5YN/A